SouthernWorldwide.com – Creatine, a widely recognized supplement for muscle enhancement, may offer a new avenue in combating depression symptoms, according to recent research.
A comprehensive review, published in the journal Brain Medicine by Genomic Press, suggests that creatine monohydrate could serve as a beneficial adjunctive therapy for major depressive disorder. However, the current evidence is still considered preliminary.
Researchers based in Canada conducted an analysis of five randomized controlled trials. These trials aimed to assess the effects of creatine monohydrate consumption on mental health outcomes.
The studies examined involved different conditions. Four of the trials focused specifically on major depressive disorder, while one investigated bipolar disorder with a current depressive episode.
One particular trial demonstrated notable improvement in women with depression. These participants received 5 grams of creatine daily, in addition to the antidepressant escitalopram. The positive effects were observed after an eight-week period. Another study indicated benefits when creatine was incorporated as a supplement to cognitive behavioral therapy.
Conversely, other studies involving adolescent girls did not find any significant benefits from various creatine dosages after eight weeks. Similarly, the study on bipolar depression showed no substantial improvements when 6 grams of creatine were added to their medication regimen for six weeks.
In a statement, the researchers highlighted previous findings indicating that individuals with mood disorders exhibit different patterns of creatine processing in the brain. Given creatine’s role in energy production, some scientists hypothesize that disruptions in this process might contribute to the development of depression.
While creatine has also been linked to increased levels of dopamine and serotonin—neurotransmitters that are common targets for antidepressant medications—the study’s authors emphasized that the connection between brain creatine and mood remains correlational. They stressed that depression is a complex condition with numerous contributing factors.
Bassam Jeryous Fares, the lead author of the study and a student at the University of Ottawa’s Faculty of Medicine, commented that the findings are “interesting, but not a verdict.”
“Two trials pointed one way and three pointed another,” he stated. “That is not the kind of evidence on which you change clinical practice. It is the kind that tells you the question is worth further exploration.”
Nicholas Fabiano, the corresponding author and a psychiatry resident at the University of Ottawa, added that creatine “appears to be a safe intervention.” He noted that reported side effects were minor and primarily consisted of mild stomach pain.
“We cannot yet reliably say that creatine helps with depressive symptoms or if the findings are generalizable to everyone,” he cautioned.
Dr. Thea Gallagher, a psychologist and director of wellness programs at NYU Langone, explained that although creatine is best known for its role in muscle performance, it also plays a part in the brain’s energy production and utilization.
Dr. Gallagher emphasized that the research suggests creatine may be most effective when used in conjunction with established depression treatments, rather than as a standalone solution.
“This research is encouraging because it adds to a growing body of evidence suggesting that supporting brain energy metabolism may be another pathway for improving depression symptoms,” she commented.
“It’s exciting whenever we identify another potential tool that could complement existing treatments, particularly one that is relatively inexpensive and widely available.”
The researchers acknowledged that the new study is a review of existing research rather than a novel clinical trial, which they consider a limitation. They also stated that “larger, well-controlled trials are still needed.”
Dr. Gallagher further advised that creatine should be viewed as a potentially promising addition to a treatment plan, not a replacement for psychotherapy, antidepressant medication, regular exercise, or healthy sleep habits.
“While creatine has a strong safety profile for most healthy adults, it’s still important to talk with your healthcare provider before starting any supplement — particularly if you have kidney disease, are pregnant or have other medical conditions,” she recommended.
For individuals experiencing symptoms of depression, Dr. Gallagher strongly advises seeking evidence-based mental healthcare.
She noted that depression is a “highly heterogeneous condition, so we still don’t know which patients are most likely to benefit or what the optimal treatment approach looks like.”
Dr. Gallagher also cautioned that supplements can sometimes generate “early enthusiasm” that may diminish as larger studies reveal “more modest effects.”
“Right now, I’d describe creatine as promising but not definitive,” she concluded. “It’s an area that deserves continued research, but it’s not something people should view as a standalone treatment for depression.”
